Pharmaceutical Investing Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with Pint Pharma
Pharmaceutical Investing Onconova Presents Promising Data from Phase 2 Expansion Study of Oral Rigosertib and Azacitidine
